OPKO Health Share Holder Equity 2012-2026 | OPK
OPKO Health share holder equity from 2012 to 2026. Share holder equity can be defined as the sum of preferred and common equity items
|
OPKO Health Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025 | $1,268 |
| 2024 | $1,365 |
| 2023 | $1,389 |
| 2022 | $1,562 |
| 2021 | $1,685 |
| 2020 | $1,672 |
| 2019 | $1,615 |
| 2018 | $1,791 |
| 2017 | $1,844 |
| 2016 | $2,092 |
| 2015 | $1,980 |
| 2014 | $836 |
| 2013 | $873 |
| 2012 | $179 |
| 2011 | $161 |
|
OPKO Health Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2026-06-30 | $1,184 |
| 2026-03-31 | $1,205 |
| 2025-12-31 | $1,268 |
| 2025-09-30 | $1,305 |
| 2025-06-30 | $1,297 |
| 2025-03-31 | $1,312 |
| 2024-12-31 | $1,365 |
| 2024-09-30 | $1,403 |
| 2024-06-30 | $1,395 |
| 2024-03-31 | $1,253 |
| 2023-12-31 | $1,389 |
| 2023-09-30 | $1,445 |
| 2023-06-30 | $1,535 |
| 2023-03-31 | $1,552 |
| 2022-12-31 | $1,562 |
| 2022-09-30 | $1,629 |
| 2022-06-30 | $1,719 |
| 2022-03-31 | $1,615 |
| 2021-12-31 | $1,685 |
| 2021-09-30 | $1,766 |
| 2021-06-30 | $1,743 |
| 2021-03-31 | $1,697 |
| 2020-12-31 | $1,672 |
| 2020-09-30 | $1,624 |
| 2020-06-30 | $1,588 |
| 2020-03-31 | $1,549 |
| 2019-12-31 | $1,615 |
| 2019-09-30 | $1,642 |
| 2019-06-30 | $1,709 |
| 2019-03-31 | $1,763 |
| 2018-12-31 | $1,791 |
| 2018-09-30 | $1,789 |
| 2018-06-30 | $1,810 |
| 2018-03-31 | $1,823 |
| 2017-12-31 | $1,844 |
| 2017-09-30 | $2,089 |
| 2017-06-30 | $2,107 |
| 2017-03-31 | $2,107 |
| 2016-12-31 | $2,092 |
| 2016-09-30 | $2,105 |
| 2016-06-30 | $2,016 |
| 2016-03-31 | $1,998 |
| 2015-12-31 | $1,980 |
| 2015-09-30 | $1,969 |
| 2015-06-30 | $827 |
| 2015-03-31 | $813 |
| 2014-12-31 | $836 |
| 2014-09-30 | $887 |
| 2014-06-30 | $913 |
| 2014-03-31 | $831 |
| 2013-12-31 | $873 |
| 2013-09-30 | $868 |
| 2013-06-30 | $312 |
| 2013-03-31 | $320 |
| 2012-12-31 | $179 |
| 2012-09-30 | $146 |
| 2012-06-30 | $152 |
| 2012-03-31 | $155 |
| 2011-12-31 | $161 |
| 2011-09-30 | $102 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.172B | $0.607B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $237.152B | 26.92 |
| Intuitive Surgical (ISRG) | United States | $133.242B | 45.17 |
| Edwards Lifesciences (EW) | United States | $49.369B | 30.51 |
| IQVIA Holdings (IQV) | United States | $44.388B | 23.74 |
| Waters (WAT) | United States | $40.978B | 30.49 |
| IDEXX Laboratories (IDXX) | United States | $40.236B | 35.92 |
| Alcon (ALC) | Switzerland | $33.515B | 20.78 |
| DexCom (DXCM) | United States | $32.623B | 33.90 |
| Mettler-Toledo (MTD) | United States | $26.657B | 29.64 |
| STERIS (STE) | Ireland | $20.502B | 20.18 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.610B | 0.00 |
| Coloplast (CLPBY) | Denmark | $14.694B | 17.62 |
| Penumbra (PEN) | United States | $12.543B | 82.71 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.332B | 8.63 |
| Glaukos (GKOS) | United States | $10.126B | 0.00 |
| Globus Medical (GMED) | United States | $10.028B | 15.18 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.442B | 28.15 |
| Teleflex (TFX) | United States | $5.467B | 14.74 |
| LivaNova (LIVN) | United Kingdom | $4.378B | 22.14 |
| Integer Holdings (ITGR) | United States | $4.291B | 19.88 |
| Pulse Biosciences (PLSE) | United States | $3.820B | 0.00 |
| Veracyte (VCYT) | United States | $3.227B | 26.41 |
| TransMedics (TMDX) | United States | $3.044B | 44.72 |
| AxoGen (AXGN) | United States | $2.418B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.134B | 26.93 |
| Elekta AB (EKTAY) | Sweden | $1.948B | 18.22 |
| Nihon Kohden (NHNKY) | Japan | $1.688B | 15.46 |
| Alphatec Holdings (ATEC) | United States | $1.646B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.343B | 0.00 |
| Artivion (AORT) | United States | $1.237B | 47.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.220B | 6.35 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.133B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.105B | 0.00 |
| IRadimed (IRMD) | United States | $1.054B | 46.04 |
| Beta Bionics (BBNX) | United States | $0.865B | 0.00 |
| SiBone (SIBN) | United States | $0.823B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.813B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.712B | 17.14 |
| AngioDynamics (ANGO) | United States | $0.648B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.607B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.561B | 1617.00 |
| Tactile Systems Technology (TCMD) | United States | $0.510B | 20.84 |
| NeuroPace (NPCE) | United States | $0.489B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.447B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.417B | 0.00 |
| 908 Devices (MASS) | United States | $0.412B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.401B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.370B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.359B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.298B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.234B | 0.00 |
| Neuronetics (STIM) | United States | $0.213B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.161B | 0.00 |
| FocalTherics (FOCL) | France | $0.153B | 0.00 |
| Inogen (INGN) | United States | $0.138B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.082B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.070B | 23.00 |
| DarioHealth (DRIO) | United States | $0.066B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.058B | 0.00 |
| Envoy Medical (COCH) | United States | $0.055B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.054B | 0.00 |
| Vaso (VASO) | United States | $0.051B | 29.09 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.051B | 0.00 |
| Precision Optics (POCI) | United States | $0.046B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.036B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| PAVmed (PAVM) | United States | $0.031B | 0.00 |
| Accuray (ARAY) | United States | $0.028B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| ENvue Medical (FEED) | United States | $0.001B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |